Detalles de la búsqueda
1.
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study.
Lancet Oncol
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38823410
2.
Comparison of aprepitant versus desloratadine for EGFR-TKI-induced pruritus: A randomized phase 2 clinical trial.
Cancer
; 128(22): 3969-3976, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36197287
3.
The perception gap of chemotherapy-induced adverse events between doctors and cancer patients: an observational study in China.
Support Care Cancer
; 29(3): 1543-1548, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728801
4.
New Insight into the Mechanism of Multivalent Ion Hybrid Supercapacitor: From the Effect of Potential Window Viewpoint.
Small
; 16(46): e2003403, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33107205
5.
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
Mol Cancer
; 18(1): 7, 2019 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626401
6.
Progression-free survival and one-year milestone survival as surrogates for overall survival in previously treated advanced non-small cell lung cancer.
Int J Cancer
; 144(11): 2854-2866, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30430561
7.
Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China.
Oncologist
; 24(Suppl 1): S11-S20, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819827
8.
Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysis.
Future Oncol
; 15(21): 2479-2488, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31238738
9.
Bevacizumab in combination with different platinum-based doublets in the first-line treatment for advanced nonsquamous non-small-cell lung cancer: A network meta-analysis.
Int J Cancer
; 142(8): 1676-1688, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29171009
10.
Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.
Int J Cancer
; 143(7): 1569-1577, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29667174
11.
Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis.
Oncologist
; 23(5): 603-616, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29330211
12.
Retraction Note: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells.
BMC Cancer
; 23(1): 386, 2023 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37122006
13.
p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells.
BMC Cancer
; 18(1): 641, 2018 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29879950
14.
Optimal prophylaxis of chemotherapy-induced nausea and vomiting for moderately emetogenic chemotherapy: a meta-analysis.
Future Oncol
; 14(19): 1933-1941, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019968
15.
Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
Oncologist
; 22(1): 53-60, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27789776
16.
Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).
BMC Cancer
; 17(1): 269, 2017 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28410578
17.
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.
Mol Cancer
; 20(1): 37, 2021 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33622313
18.
Intercalation chemistry engineering strategy enabled high mass loading and ultrastable electrodes for High-Performance aqueous electrochemical energy storage devices.
J Colloid Interface Sci
; 660: 32-41, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241869
19.
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC.
Clin Cancer Res
; 30(12): 2636-2646, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578683
20.
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis.
Cancer Med
; 13(7): e7175, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38597130